The override of former President Trump's veto of the National Defense Authorization Act of 2021 resulted in the enactment of broad amendments to the US anti-money laundering regime. Of particular note is the inclusion of the...more
1/28/2021
/ Anti-Money Laundering ,
Beneficial Owner ,
Closely Held Businesses ,
Corporate Transparency Act ,
Covered Entities ,
Customer Due Diligence (CDD) ,
FinCEN ,
Limited Liability Company (LLC) ,
NDAA ,
Shell Corporations ,
Special Purpose Vehicles
The novel coronavirus referred to as SARS-CoV-2 and the disease that the virus causes (“COVID-19”) has created significant challenges for companies and employees across the United States as quarantine, self-isolation, and...more
The dramatic decline in asset values caused by the emergence of COVID-19 as a significant health threat, combined with historically high gift tax exemptions and historically low interest rates make now an opportune time to...more
As the rest of the world backed away from the deal table, confident US corporates continued buying businesses—especially in the life sciences and TMT sectors, and particularly in the domestic market.
US dealmakers had a...more
2/1/2020
/ Acquisitions ,
Antitrust Provisions ,
Canada ,
CFIUS ,
Department of Justice (DOJ) ,
Domestic Dealmaking ,
Family Businesses ,
Federal Trade Commission (FTC) ,
FIRRMA ,
Foreign Acquisitions ,
Foreign Investment ,
Global Dealmaking ,
Global Economy ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Pre-Merger Filing Requirements ,
Private Equity ,
Privately Held Corporations ,
Trade Wars ,
UK ,
United States-Mexico-Canada Agreement (USMCA)